Provenance
SPS national PGD templates for antimicrobial treatments are created by SPS, with support from the National Institute for Health and Care Excellence (NICE), the Royal College of General Practitioners (RCGP), the Advisory Committee on Antimicrobial Prescribing, Resistance and Healthcare Associated Infection (ARPHAI), UK Health Security Agency (UKHSA) and NHS England (NHSE).
NICE guidance update 2024
NICE are currently updating their guidance: Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management – it is expected to be published in March 2024, after being delayed initially from December 2023, then February 2024.
Version 1.1 of the SPS ‘Benzylpenicillin injection for suspected meningitis’ PGD template, reflecting current NICE guidance, expired on the 17th January 2024 and has been removed from the SPS website.
It is anticipated that the updated benzylpenicillin PGD template, reflecting the updated NICE guidance once released, will be published on this page in Spring 2024.
More antimicrobial PGDs
- Clarithromycin for sinusitis
- Aciclovir for shingles
- Clarithromycin for otitis media
- Clarithromycin for infected insect bites or stings
- Fusidic acid 2% cream for impetigo
- Fluticasone furoate nasal spray for sinusitis
- Otigo (phenazone with lidocaine) ear drops for otitis media
- Penicillin V (phenoxymethylpenicillin) for sinusitis
- Erythromycin for infected insect bites or stings
- Amoxicillin for otitis media
- Clarithromycin for impetigo
- Erythromycin for sore throat
- Flucloxacillin for infected insect bites or stings
- Flucloxacillin for impetigo
- Hydrogen peroxide 1% cream for impetigo
- Erythromycin for otitis media
- Doxycycline for sinusitis
- Mometasone furoate monohydrate nasal spray for sinusitis
- Valaciclovir for shingles
- Erythromycin for sinusitis
All PGD templates
Templates
Update history
- Anticipated publication date of NICE guidance updated from February 2024 to March 2024
- Expired template V1.1 removed - wording updated re anticipated publication of Version 2.0 pending updated NICE guidance publication.
- Page wording updated
- Revised wording regarding ceftriaxone
- Advisory text added regarding anticipated updated NICE guidance/impact on release of updated PGD templates.
- Title, URL and summary amended.
- Updated PGD template - expiry extended by 12 months to a total of 3 years.
- Published